Cite
Chulay J, Biron K, Wang L, et al. Development of novel benzimidazole riboside compounds for treatment of cytomegalovirus disease. Adv Exp Med Biol. 1999;458:129-34doi: 10.1007/978-1-4615-4743-3_12.
Chulay, J., Biron, K., Wang, L., Underwood, M., Chamberlain, S., Frick, L., Good, S., Davis, M., Harvey, R., Townsend, L., Drach, J., & Koszalka, G. (1999). Development of novel benzimidazole riboside compounds for treatment of cytomegalovirus disease. Advances in experimental medicine and biology, 458129-34. https://doi.org/10.1007/978-1-4615-4743-3_12
Chulay, J, et al. "Development of novel benzimidazole riboside compounds for treatment of cytomegalovirus disease." Advances in experimental medicine and biology vol. 458 (1999): 129-34. doi: https://doi.org/10.1007/978-1-4615-4743-3_12
Chulay J, Biron K, Wang L, Underwood M, Chamberlain S, Frick L, Good S, Davis M, Harvey R, Townsend L, Drach J, Koszalka G. Development of novel benzimidazole riboside compounds for treatment of cytomegalovirus disease. Adv Exp Med Biol. 1999;458:129-34. doi: 10.1007/978-1-4615-4743-3_12. PMID: 10549385.
Copy
Download .nbib